ID

32660

Descrizione

Patient Preference of h-Patch vs. Pen or Needle/Syringe as Insulin Administration Device; ODM derived from: https://clinicaltrials.gov/show/NCT00453934

collegamento

https://clinicaltrials.gov/show/NCT00453934

Keywords

versioni (1)
  1. 10/11/18 10/11/18 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

10 novembre 2018

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Type 1 Diabetes NCT00453934

Inglese

Eligibility Type 1 Diabetes NCT00453934

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. diagnosis of type 1or type 2 diabetes mellitus for at least a year
Descrizione

Insulin-Dependent Diabetes Mellitus Disease length | Non-Insulin-Dependent Diabetes Mellitus Disease length

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0011854
UMLS CUI [1,2]
C0872146
UMLS CUI [2,1]
C0011860
UMLS CUI [2,2]
C0872146
2. stable insulin regimen for at least 3 months consisting of multiple daily injections of human regular or rapid acting insulin at meal times and long or intermediate acting insulin as basal. in this protocol multiple daily injections requires at least three injections daily.
Descrizione

Insulin regime Stable | Injection Multiple Daily | Regular Insulin, Human | Short-Acting Insulin Mealtimes | Insulin, Long-Acting | Intermediate-acting insulin | Basal insulin

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0557978
UMLS CUI [1,2]
C0205360
UMLS CUI [2,1]
C1533685
UMLS CUI [2,2]
C0439064
UMLS CUI [2,3]
C0332173
UMLS CUI [3]
C0795635
UMLS CUI [4,1]
C0356365
UMLS CUI [4,2]
C0587119
UMLS CUI [5]
C0304870
UMLS CUI [6]
C0304869
UMLS CUI [7]
C0650607
3. total daily insulin dose between 50 and 80 units.
Descrizione

Insulin Total Dose U/day

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0021641
UMLS CUI [1,2]
C2986497
UMLS CUI [1,3]
C0456683
4. if patient is type 2, can be treated with metformin and/or a thiazolidinedione and/or a sulfonylurea, but other diabetes drugs including α-glucosidase inhibitors, meglitinides, pramlintide exenatide, and dpp-iv's are excluded.
Descrizione

Diabetes Mellitus, Non-Insulin-Dependent | Metformin | Thiazolidinediones | Sulfonylureas | alpha-Glucosidase Inhibitors Excluded | Meglitinide Excluded | Pramlintide Excluded | Exenatide Excluded | Dipeptidyl-Peptidase IV Inhibitors Excluded

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2]
C0025598
UMLS CUI [3]
C1257987
UMLS CUI [4]
C0038766
UMLS CUI [5,1]
C1299007
UMLS CUI [5,2]
C0332196
UMLS CUI [6,1]
C0065880
UMLS CUI [6,2]
C0332196
UMLS CUI [7,1]
C0537551
UMLS CUI [7,2]
C0332196
UMLS CUI [8,1]
C0167117
UMLS CUI [8,2]
C0332196
UMLS CUI [9,1]
C1827106
UMLS CUI [9,2]
C0332196
5. hba1c > 7.0% and < 9.0%.
Descrizione

Hemoglobin A1c measurement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0474680
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. recurrent major hypoglycemia or prolonged unstable blood glucose control (as judged by the investigator).
Descrizione

Hypoglycemia Major | Blood Glucose Control Unstable Prolonged

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0020615
UMLS CUI [1,2]
C0205164
UMLS CUI [2,1]
C0005802
UMLS CUI [2,2]
C2587213
UMLS CUI [2,3]
C0443343
UMLS CUI [2,4]
C0439590
2. use of other diabetes drugs including α-glucosidase inhibitors, meglitinides, pramlintide, exenatide or dpp-iv inhibitors (metformin and/or a thiazolidinedione and/or a sulfonylurea are allowed).
Descrizione

Antidiabetics | alpha-Glucosidase Inhibitors | Meglitinide | Pramlintide | exenatide | Dipeptidyl-Peptidase IV Inhibitors | Metformin allowed | Thiazolidinediones allowed | Sulfonylureas allowed

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0935929
UMLS CUI [2]
C1299007
UMLS CUI [3]
C0065880
UMLS CUI [4]
C0537551
UMLS CUI [5]
C0167117
UMLS CUI [6]
C1827106
UMLS CUI [7,1]
C0025598
UMLS CUI [7,2]
C0683607
UMLS CUI [8,1]
C1257987
UMLS CUI [8,2]
C0683607
UMLS CUI [9,1]
C0038766
UMLS CUI [9,2]
C0683607
3. intend to use any other concomitant drug therapy (prescription or over-the-counter medications) that can affect blood glucose levels.
Descrizione

Pharmacotherapy Affecting Blood glucose level | Non-Prescription Drugs Affecting Blood glucose level

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0013216
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0428554
UMLS CUI [2,1]
C0013231
UMLS CUI [2,2]
C0392760
UMLS CUI [2,3]
C0428554
4. have used systemic glucocorticoids within 1 month prior to screening or currently on glucocorticoids.
Descrizione

Glucocorticoids, Systemic | Glucocorticoids

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3540777
UMLS CUI [2]
C0017710
5. have a history of drug or alcohol abuse within 1 year prior to screening visit.
Descrizione

Substance Use Disorders

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0038586
6. have a history or presence of cardiovascular, respiratory, hepatic, renal, gastrointestinal, or neurological disease that would, in the investigator's opinion, preclude safe participation in the study.
Descrizione

Cardiovascular Disease Study Subject Participation Status Excluded | Respiration Disorder Study Subject Participation Status Excluded | Liver disease Study Subject Participation Status Excluded | Kidney Disease Study Subject Participation Status Excluded | Gastrointestinal Disease Study Subject Participation Status Excluded | Nervous system disorder Study Subject Participation Status Excluded

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0007222
UMLS CUI [1,2]
C2348568
UMLS CUI [1,3]
C0332196
UMLS CUI [2,1]
C0035204
UMLS CUI [2,2]
C2348568
UMLS CUI [2,3]
C0332196
UMLS CUI [3,1]
C0023895
UMLS CUI [3,2]
C2348568
UMLS CUI [3,3]
C0332196
UMLS CUI [4,1]
C0022658
UMLS CUI [4,2]
C2348568
UMLS CUI [4,3]
C0332196
UMLS CUI [5,1]
C0017178
UMLS CUI [5,2]
C2348568
UMLS CUI [5,3]
C0332196
UMLS CUI [6,1]
C0027765
UMLS CUI [6,2]
C2348568
UMLS CUI [6,3]
C0332196
7. have a history of major surgery, e.g. laparotomy, thoracotomy, open orthopedic procedure, etc. within 3 months prior to screening visit.
Descrizione

Major surgery | Laparotomy | Thoracotomy | Orthopedic Procedure Open

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0679637
UMLS CUI [2]
C0023038
UMLS CUI [3]
C0039991
UMLS CUI [4,1]
C0524852
UMLS CUI [4,2]
C0175566
8. evidence of significant neuropsychiatric disease.
Descrizione

Neuropsychiatric syndrome

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3203509
9. have participated in a medical, surgical, or pharmaceutical investigational new drug/device study in the last 30 days or ≤ 5 half-lives of the investigational drug, whichever is longer, prior to screening visit.
Descrizione

Study Subject Participation Status | Investigational New Drugs | Investigational Medical Device | Clinical Trial | Clinical Trial Surgical | Pharmaceutical Preparations Investigational

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0013230
UMLS CUI [3]
C2346570
UMLS CUI [4]
C0008976
UMLS CUI [5,1]
C0008976
UMLS CUI [5,2]
C0543467
UMLS CUI [6,1]
C0013227
UMLS CUI [6,2]
C1517586
10. blood donation of 500 ml or more in the last 2 months prior to screening visit.
Descrizione

Blood Donation Amount

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0005794
UMLS CUI [1,2]
C1265611
11. evidence of significant active hematological disease.
Descrizione

Hematological Disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0018939
12. acute infection with fever.
Descrizione

Communicable Disease With Fever

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0332287
UMLS CUI [1,3]
C0015967
13. hemoglobin < 10 g/dl; ast, alt ≥ 1.5 times the upper reference limit at screening.
Descrizione

Hemoglobin measurement | Aspartate aminotransferase increased | Alanine aminotransferase increased

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0518015
UMLS CUI [2]
C0151904
UMLS CUI [3]
C0151905
14. uncontrolled treated/untreated hypertension (systolic blood pressure > 155 mmhg and diastolic blood pressure > 90 mmhg).
Descrizione

Uncontrolled hypertension Treated | Uncontrolled hypertension Untreated | Systolic Pressure | Diastolic blood pressure

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1868885
UMLS CUI [1,2]
C1522326
UMLS CUI [2,1]
C1868885
UMLS CUI [2,2]
C0332155
UMLS CUI [3]
C0871470
UMLS CUI [4]
C0428883
15. history of proliferative retinopathy or maculopathy requiring acute treatment
Descrizione

Proliferative retinopathy | Disorder of macula of retina Treatment required for

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0339467
UMLS CUI [2,1]
C0730362
UMLS CUI [2,2]
C0332121
16. mental incapacity, unwillingness or language barrier precluding adequate understanding or co-operation.
Descrizione

Mental handicap Preventing Comprehension | Comprehension Unwilling | Language Barrier Preventing Comprehension | Mental handicap Preventing Cooperation | Cooperation Unwilling | Language Barrier Preventing Cooperation

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1306341
UMLS CUI [1,2]
C1292733
UMLS CUI [1,3]
C0162340
UMLS CUI [2,1]
C0162340
UMLS CUI [2,2]
C0558080
UMLS CUI [3,1]
C0237167
UMLS CUI [3,2]
C1292733
UMLS CUI [3,3]
C0162340
UMLS CUI [4,1]
C1306341
UMLS CUI [4,2]
C1292733
UMLS CUI [4,3]
C0392337
UMLS CUI [5,1]
C0392337
UMLS CUI [5,2]
C0558080
UMLS CUI [6,1]
C0237167
UMLS CUI [6,2]
C1292733
UMLS CUI [6,3]
C0392337
17. any condition that the investigator and/or sponsor feel would interfere with trial participation or evaluation of results
Descrizione

Condition Interferes with Study Subject Participation Status | Condition Interferes with Evaluation Research results

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C2348568
UMLS CUI [2,1]
C0348080
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C1261322
UMLS CUI [2,4]
C0683954
18. pregnancy, breast-feeding, intention of becoming pregnant for female patients of child-bearing potential.
Descrizione

Pregnancy | Breast Feeding | Childbearing Potential Planned Pregnancy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3,1]
C3831118
UMLS CUI [3,2]
C0032992
Ritorna all'inizio della pagina

Similar models

Eligibility Type 1 Diabetes NCT00453934

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Insulin-Dependent Diabetes Mellitus Disease length | Non-Insulin-Dependent Diabetes Mellitus Disease length
Item
1. diagnosis of type 1or type 2 diabetes mellitus for at least a year
boolean
C0011854 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
C0011860 (UMLS CUI [2,1])
C0872146 (UMLS CUI [2,2])
Insulin regime Stable | Injection Multiple Daily | Regular Insulin, Human | Short-Acting Insulin Mealtimes | Insulin, Long-Acting | Intermediate-acting insulin | Basal insulin
Item
2. stable insulin regimen for at least 3 months consisting of multiple daily injections of human regular or rapid acting insulin at meal times and long or intermediate acting insulin as basal. in this protocol multiple daily injections requires at least three injections daily.
boolean
C0557978 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C1533685 (UMLS CUI [2,1])
C0439064 (UMLS CUI [2,2])
C0332173 (UMLS CUI [2,3])
C0795635 (UMLS CUI [3])
C0356365 (UMLS CUI [4,1])
C0587119 (UMLS CUI [4,2])
C0304870 (UMLS CUI [5])
C0304869 (UMLS CUI [6])
C0650607 (UMLS CUI [7])
Insulin Total Dose U/day
Item
3. total daily insulin dose between 50 and 80 units.
boolean
C0021641 (UMLS CUI [1,1])
C2986497 (UMLS CUI [1,2])
C0456683 (UMLS CUI [1,3])
Diabetes Mellitus, Non-Insulin-Dependent | Metformin | Thiazolidinediones | Sulfonylureas | alpha-Glucosidase Inhibitors Excluded | Meglitinide Excluded | Pramlintide Excluded | Exenatide Excluded | Dipeptidyl-Peptidase IV Inhibitors Excluded
Item
4. if patient is type 2, can be treated with metformin and/or a thiazolidinedione and/or a sulfonylurea, but other diabetes drugs including α-glucosidase inhibitors, meglitinides, pramlintide exenatide, and dpp-iv's are excluded.
boolean
C0011860 (UMLS CUI [1])
C0025598 (UMLS CUI [2])
C1257987 (UMLS CUI [3])
C0038766 (UMLS CUI [4])
C1299007 (UMLS CUI [5,1])
C0332196 (UMLS CUI [5,2])
C0065880 (UMLS CUI [6,1])
C0332196 (UMLS CUI [6,2])
C0537551 (UMLS CUI [7,1])
C0332196 (UMLS CUI [7,2])
C0167117 (UMLS CUI [8,1])
C0332196 (UMLS CUI [8,2])
C1827106 (UMLS CUI [9,1])
C0332196 (UMLS CUI [9,2])
Hemoglobin A1c measurement
Item
5. hba1c > 7.0% and < 9.0%.
boolean
C0474680 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Hypoglycemia Major | Blood Glucose Control Unstable Prolonged
Item
1. recurrent major hypoglycemia or prolonged unstable blood glucose control (as judged by the investigator).
boolean
C0020615 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
C0005802 (UMLS CUI [2,1])
C2587213 (UMLS CUI [2,2])
C0443343 (UMLS CUI [2,3])
C0439590 (UMLS CUI [2,4])
Antidiabetics | alpha-Glucosidase Inhibitors | Meglitinide | Pramlintide | exenatide | Dipeptidyl-Peptidase IV Inhibitors | Metformin allowed | Thiazolidinediones allowed | Sulfonylureas allowed
Item
2. use of other diabetes drugs including α-glucosidase inhibitors, meglitinides, pramlintide, exenatide or dpp-iv inhibitors (metformin and/or a thiazolidinedione and/or a sulfonylurea are allowed).
boolean
C0935929 (UMLS CUI [1])
C1299007 (UMLS CUI [2])
C0065880 (UMLS CUI [3])
C0537551 (UMLS CUI [4])
C0167117 (UMLS CUI [5])
C1827106 (UMLS CUI [6])
C0025598 (UMLS CUI [7,1])
C0683607 (UMLS CUI [7,2])
C1257987 (UMLS CUI [8,1])
C0683607 (UMLS CUI [8,2])
C0038766 (UMLS CUI [9,1])
C0683607 (UMLS CUI [9,2])
Pharmacotherapy Affecting Blood glucose level | Non-Prescription Drugs Affecting Blood glucose level
Item
3. intend to use any other concomitant drug therapy (prescription or over-the-counter medications) that can affect blood glucose levels.
boolean
C0013216 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0428554 (UMLS CUI [1,3])
C0013231 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0428554 (UMLS CUI [2,3])
Glucocorticoids, Systemic | Glucocorticoids
Item
4. have used systemic glucocorticoids within 1 month prior to screening or currently on glucocorticoids.
boolean
C3540777 (UMLS CUI [1])
C0017710 (UMLS CUI [2])
Substance Use Disorders
Item
5. have a history of drug or alcohol abuse within 1 year prior to screening visit.
boolean
C0038586 (UMLS CUI [1])
Cardiovascular Disease Study Subject Participation Status Excluded | Respiration Disorder Study Subject Participation Status Excluded | Liver disease Study Subject Participation Status Excluded | Kidney Disease Study Subject Participation Status Excluded | Gastrointestinal Disease Study Subject Participation Status Excluded | Nervous system disorder Study Subject Participation Status Excluded
Item
6. have a history or presence of cardiovascular, respiratory, hepatic, renal, gastrointestinal, or neurological disease that would, in the investigator's opinion, preclude safe participation in the study.
boolean
C0007222 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C0332196 (UMLS CUI [1,3])
C0035204 (UMLS CUI [2,1])
C2348568 (UMLS CUI [2,2])
C0332196 (UMLS CUI [2,3])
C0023895 (UMLS CUI [3,1])
C2348568 (UMLS CUI [3,2])
C0332196 (UMLS CUI [3,3])
C0022658 (UMLS CUI [4,1])
C2348568 (UMLS CUI [4,2])
C0332196 (UMLS CUI [4,3])
C0017178 (UMLS CUI [5,1])
C2348568 (UMLS CUI [5,2])
C0332196 (UMLS CUI [5,3])
C0027765 (UMLS CUI [6,1])
C2348568 (UMLS CUI [6,2])
C0332196 (UMLS CUI [6,3])
Major surgery | Laparotomy | Thoracotomy | Orthopedic Procedure Open
Item
7. have a history of major surgery, e.g. laparotomy, thoracotomy, open orthopedic procedure, etc. within 3 months prior to screening visit.
boolean
C0679637 (UMLS CUI [1])
C0023038 (UMLS CUI [2])
C0039991 (UMLS CUI [3])
C0524852 (UMLS CUI [4,1])
C0175566 (UMLS CUI [4,2])
Neuropsychiatric syndrome
Item
8. evidence of significant neuropsychiatric disease.
boolean
C3203509 (UMLS CUI [1])
Study Subject Participation Status | Investigational New Drugs | Investigational Medical Device | Clinical Trial | Clinical Trial Surgical | Pharmaceutical Preparations Investigational
Item
9. have participated in a medical, surgical, or pharmaceutical investigational new drug/device study in the last 30 days or ≤ 5 half-lives of the investigational drug, whichever is longer, prior to screening visit.
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C2346570 (UMLS CUI [3])
C0008976 (UMLS CUI [4])
C0008976 (UMLS CUI [5,1])
C0543467 (UMLS CUI [5,2])
C0013227 (UMLS CUI [6,1])
C1517586 (UMLS CUI [6,2])
Blood Donation Amount
Item
10. blood donation of 500 ml or more in the last 2 months prior to screening visit.
boolean
C0005794 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
Hematological Disease
Item
11. evidence of significant active hematological disease.
boolean
C0018939 (UMLS CUI [1])
Communicable Disease With Fever
Item
12. acute infection with fever.
boolean
C0009450 (UMLS CUI [1,1])
C0332287 (UMLS CUI [1,2])
C0015967 (UMLS CUI [1,3])
Hemoglobin measurement | Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
13. hemoglobin < 10 g/dl; ast, alt ≥ 1.5 times the upper reference limit at screening.
boolean
C0518015 (UMLS CUI [1])
C0151904 (UMLS CUI [2])
C0151905 (UMLS CUI [3])
Uncontrolled hypertension Treated | Uncontrolled hypertension Untreated | Systolic Pressure | Diastolic blood pressure
Item
14. uncontrolled treated/untreated hypertension (systolic blood pressure > 155 mmhg and diastolic blood pressure > 90 mmhg).
boolean
C1868885 (UMLS CUI [1,1])
C1522326 (UMLS CUI [1,2])
C1868885 (UMLS CUI [2,1])
C0332155 (UMLS CUI [2,2])
C0871470 (UMLS CUI [3])
C0428883 (UMLS CUI [4])
Proliferative retinopathy | Disorder of macula of retina Treatment required for
Item
15. history of proliferative retinopathy or maculopathy requiring acute treatment
boolean
C0339467 (UMLS CUI [1])
C0730362 (UMLS CUI [2,1])
C0332121 (UMLS CUI [2,2])
Mental handicap Preventing Comprehension | Comprehension Unwilling | Language Barrier Preventing Comprehension | Mental handicap Preventing Cooperation | Cooperation Unwilling | Language Barrier Preventing Cooperation
Item
16. mental incapacity, unwillingness or language barrier precluding adequate understanding or co-operation.
boolean
C1306341 (UMLS CUI [1,1])
C1292733 (UMLS CUI [1,2])
C0162340 (UMLS CUI [1,3])
C0162340 (UMLS CUI [2,1])
C0558080 (UMLS CUI [2,2])
C0237167 (UMLS CUI [3,1])
C1292733 (UMLS CUI [3,2])
C0162340 (UMLS CUI [3,3])
C1306341 (UMLS CUI [4,1])
C1292733 (UMLS CUI [4,2])
C0392337 (UMLS CUI [4,3])
C0392337 (UMLS CUI [5,1])
C0558080 (UMLS CUI [5,2])
C0237167 (UMLS CUI [6,1])
C1292733 (UMLS CUI [6,2])
C0392337 (UMLS CUI [6,3])
Condition Interferes with Study Subject Participation Status | Condition Interferes with Evaluation Research results
Item
17. any condition that the investigator and/or sponsor feel would interfere with trial participation or evaluation of results
boolean
C0348080 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C1261322 (UMLS CUI [2,3])
C0683954 (UMLS CUI [2,4])
Pregnancy | Breast Feeding | Childbearing Potential Planned Pregnancy
Item
18. pregnancy, breast-feeding, intention of becoming pregnant for female patients of child-bearing potential.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C3831118 (UMLS CUI [3,1])
C0032992 (UMLS CUI [3,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial